相关实验视频

Updated: Mar 4, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

抑制CDK8/CDK19可以恢复T细胞恒温在原发性免疫性血栓塞缩小症

Yan-Ming Wang¹, Hu Zhou², Shaoqiu Leng³

¹Department of Hematology, Yantai Yuhuangding Hospital Affiliated to Qingdao University, Yantai, People's Republic of China, Yantai, China.

|March 2, 2026

概括

通过AS2863619抑制CDK8/CDK19,促进调节性T细胞转化,恢复免疫平衡,并改善免疫血栓减小的小鼠模型的结果.

科学领域:

免疫学免疫学免疫学
细胞生物学细胞生物学
药理学药理学是指药理学的学科.

背景情况:

调节性T细胞 (Tregs) 对于免疫恒温至关重要.
功能障碍的Tregs与免疫血小板缺血 (ITP) 有关.
准Tregs为ITP提供了一个治疗策略.

研究的目的:

研究抑制循环林依赖激酶8 (CDK8) 和CDK19对Treg转换的影响.
阐明AS2863619介导的Treg诱导背后的机制.
在ITP的小鼠模型中评估CDK8/CDK19抑制的治疗潜力.

主要方法:

用AS2863619治疗,AS2863619是一种CDK8/CDK19.的小分子抑制剂.
对T细胞种群的分析,包括CD4+CD25+Foxp3+Tregs和CD4+CD25-效应T细胞 (Teffs).
评估STAT5和STAT3酸化,基因表达和代谢途径.
在小鼠模型中评估活跃的ITP.

主要成果:

AS2863619强大地将Teffs转化为稳定的,抑制性的Tregs.
转化依赖于STAT5信号,并涉及抑制STAT3酸化.
转录基因和代谢分析显示,Treg特异性基因程序的转变以及抑制的葡萄糖分解.
在ITP小鼠中,CDK8/CDK19抑制以STAT5依赖的方式改善了血小板缺血.

结论:

通过AS2863619抑制CDK8/CDK19是Treg诱导的有效策略.
这种方法通过促进Treg功能和抑制病原性T细胞反应来恢复免疫平衡.
抑制CDK8/CDK19代表了ITP和潜在的其他免疫相关疾病的有希望的治疗途径.

更多相关视频

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

相关概念视频

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...